These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13755287)

  • 1. Minamata disease.
    KURLAND LT; FARO SN; SIEDLER H
    Public Health Rep (1896); 1961 Aug; 76():671-2. PubMed ID: 13755287
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuropathological study of Minamata disease].
    MATSUMOTO H
    Kumamoto Med J; 1961 Nov; 35():1133-69. PubMed ID: 14471279
    [No Abstract]   [Full Text] [Related]  

  • 3. Minamata disease.
    TOKUOMI H; OKAJIMA T; KANAI J; TSUNODA M; ICHIYASU Y; MISUMI H; SHIMOMURA K; TAKABA M
    World Neurol; 1961 Jun; 2():536-45. PubMed ID: 13777231
    [No Abstract]   [Full Text] [Related]  

  • 4. Minamata disease. The outbreak of a neurologic disorder in Minamata, Japan, and its relationship to the ingestion of seafood contaminated by mercuric compounds.
    KURLAND LT; FARO SN; SIEDLER H
    World Neurol; 1960 Nov; 1():370-95. PubMed ID: 13755288
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the causes of so-called Minamata disease and its mechanism of development. XXVII. Effect of vitamin B on the mouse poisoned by thallium].
    TANIGAWA S
    Kumamoto Med J; 1961 Jun; 35():566-81. PubMed ID: 13775193
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on Minamata disease. I. Establishment of the criterion for etiological reserch in mice.
    SAITO M; OSONO T; WATANABE J; YAMAMOTO T; TAKEUCHI M; OHYAGI Y; KATSUNUMA H
    Jpn J Exp Med; 1961 Aug; 31():277-90. PubMed ID: 14496123
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathologic observations of the Minamata disease.
    TAKEUCHI T; KAMBARA T; MORIKAWA N; MATSUMOTO H; SHIRAISHI Y; ITO H
    Acta Pathol Jpn; 1959 Nov; 9(Suppl)():769-83. PubMed ID: 13919260
    [No Abstract]   [Full Text] [Related]  

  • 8. [STUDIES ON THE COURSE THAT THE CAUSATIVE AGENT OF MINAMATA DISEASE WAS FORMED, ESPECIALLY ON THE ACCUMULATION OF THE MERCURY COMPOUND IN THE FISH AND SHELLFISH OF MINAMATA BAY].
    FUJIKI M
    Kumamoto Igakkai Zasshi; 1963 Sep; 37():494-521. PubMed ID: 14092162
    [No Abstract]   [Full Text] [Related]  

  • 9. [STUDIES ON THE ORIGIN OF THE CAUSATIVE AGENT OF MINAMATA DISEASE. IV. SYNTHESIS OF METHYL(METHYLTHIO)MERCURY].
    KONDO T
    Yakugaku Zasshi; 1964 Feb; 84():137-41. PubMed ID: 14140137
    [No Abstract]   [Full Text] [Related]  

  • 10. [Medical problems concerning Minamata disease and the approach by the Japanese Society of Psychiatry and Neurology].
    Tsuda T
    Seishin Shinkeigaku Zasshi; 2008; 110(11):1120-5. PubMed ID: 19291911
    [No Abstract]   [Full Text] [Related]  

  • 11. [The pathological studies on the brain of experimental Minamata disease in cats].
    TAKABA M
    Kumamoto Igakkai Zasshi; 1962 Feb; 36():240-58. PubMed ID: 13918984
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the origin of the causative agent of Minamata disease. III. Industrial wastes containing mercury compounds from Minamata Factory.
    IRUKAYAMA K; KAI F; FUJIKI M; KONDO T
    Kumamoto Med J; 1962 Jun; 15():57-68. PubMed ID: 13956701
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contribution of Japanese researchers to progress in the field of neurology in the last 100 years: Minamata disease].
    Araki S
    Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2304-7. PubMed ID: 12373838
    [No Abstract]   [Full Text] [Related]  

  • 14. [EXPERIMENTAL STUDY ON ETIOLOGY OF MINAMATA DISEASE, ESPECIALLY ON INTOXICATION OF METHYLMERCURIC SULFIDE COMPOUNDS IN CATS].
    KOYA G
    Kumamoto Igakkai Zasshi; 1964 Feb; 38():100-39. PubMed ID: 14162553
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychiatric studies on Minamata disease].
    INOUE T
    Seishin Shinkeigaku Zasshi; 1963 Jan; 65():1-14. PubMed ID: 13956597
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical aspects of the Niigata Minamata disease].
    Shimohata T; Hirota K; Takahashi H; Nishizawa M
    Brain Nerve; 2015 Jan; 67(1):31-8. PubMed ID: 25585433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of the causal agent of Minamata disease with an organic mercury compound, methylmethyl-mercuric sulfide, with special reference to its chemical synthesis and animal experiments].
    INOUE T
    Kumamoto Med J; 1962 Dec; 36():877-89. PubMed ID: 13956598
    [No Abstract]   [Full Text] [Related]  

  • 18. Lower urinary tract symptoms in patients with Niigata Minamata disease: a case-control study 50 years after methyl mercury pollution.
    Hara N; Saito H; Takahashi K; Takeda M
    Int J Urol; 2013 Jun; 20(6):610-5. PubMed ID: 23163739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An examination of "Minamata disease general investigation and research liaison council"--The process of making uncertain the organic mercury causal theory].
    Nakano H
    Kagakushi Kenkyu; 2010; 49(254):91-100. PubMed ID: 21032857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation and identification of an organic mercury compound from the shelfish Hormomya mutabilis Gould, causal source of Minamata disease].
    HIRAKAWA K
    Kumamoto Igakkai Zasshi; 1962 Oct; 36():746-63. PubMed ID: 13954717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.